Transmissible spongiform encephalopathy (TSE) is also called prion disease. It is a rapidly progressive brain disorder for which there is no treatment or cure. TSEs include several diseases: Creuzfeldt-Jakob Disease (CJD), Gerstmann-Sträussler-Scheinker Syndrome (GSS), and Fatal Familial Insomnia (FFI).
CJD is a rare and fatal brain disease that leads to dementia. After it starts, CJD usually progresses rapidly. Eventually the person loses the ability to move, speak, or care for themselves, and they need full-time care. Most people with this disease die within six months after their illness began. Some can live as long as one year, and rarely longer.
Local Information
2023 Statistics
Incidence rate is the number of new cases of disease divided by the number of persons at risk for the disease during a particular time period.
Cases:
0*
*Includes confirmed cases in 2023.
Incidence rate per 100,000 in 2023: 0
Incidence rate per 100,000 of Creutzfeldt-Jakob Disease, All Types by year
Data Sources |
|
More Information about CJD |
|
Reporting |
Report to the Health Unit immediately by phone at 705-474-1400 or toll free at 1-800-563-2808, ext. 5229 if CJD is suspected or confirmed as per Ontario Regulation 135/18 and amendments under the Health Protection and Promotion Act, R.S.O., c.H.7. |
Should one go to childcare, school, or work if they have CJD? |
No exclusion necessary as people exposed to CJD are not contagious. |
Healthcare Provider Information |
Public Health Ontario: Creutzfeldt-Jakob Disease (CJD) Public Health Ontario Test Information Index: Creutzfeldt-Jakob Disease (CJD) Public Health Agency of Canada: Creutzfeldt-Jakob Disease Surveillance System Public Health Agency of Canada - Classic Creutzfeldt-Jakob Disease in Canada: Quick Reference Guide Infectious Disease Protocol, Appendix 1: Creutzfeldt-Jakob Disease, all types |
Contact our Communicable Disease Control (CDC) program at 705-474-1400 or toll free at 1-800-563-2808, ext. 5229, or by email to cdc@healthunit.ca for more information.
Last updated: August 2024, by CDC